162 related articles for article (PubMed ID: 30112362)
21. Maintenance dienogest therapy following adjuvant gonadotropin-releasing hormone agonist treatment after uterus-sparing surgery in adenomyosis: A retrospective cohort study.
Chan IS; Hsu TF; Shih YC; Chang YH; Wang PH; Chen YJ
Int J Gynaecol Obstet; 2023 Jun; 161(3):751-759. PubMed ID: 36527263
[TBL] [Abstract][Full Text] [Related]
22. Heavy menstrual bleeding and dysmenorrhea are improved by Magnetic Resonance Guided Focused Ultrasound Surgery (MRgFUS) of adenomyosis.
Jayaram R; Subbarayan K; Mithraprabhu S; Govindarajan M
Fertil Res Pract; 2016; 2():8. PubMed ID: 28620535
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of NovaSure
Philip CA; Le Mitouard M; Maillet L; de Saint-Hilaire P; Huissoud C; Cortet M; Dubernard G
Eur J Obstet Gynecol Reprod Biol; 2018 Aug; 227():46-51. PubMed ID: 29886317
[TBL] [Abstract][Full Text] [Related]
24. Treatment of adenomyomectomy in women with severe uterine adenomyosis using a novel technique.
Saremi A; Bahrami H; Salehian P; Hakak N; Pooladi A
Reprod Biomed Online; 2014 Jun; 28(6):753-60. PubMed ID: 24768558
[TBL] [Abstract][Full Text] [Related]
25. The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
Costanzi F; De Marco MP; Colombrino C; Ciancia M; Torcia F; Ruscito I; Bellati F; Frega A; Cozza G; Caserta D
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3432-3439. PubMed ID: 34002816
[TBL] [Abstract][Full Text] [Related]
26. Uterus-sparing operative treatment for adenomyosis.
Grimbizis GF; Mikos T; Tarlatzis B
Fertil Steril; 2014 Feb; 101(2):472-87. PubMed ID: 24289992
[TBL] [Abstract][Full Text] [Related]
27. Outcome of uterine functional structures protection by fertility preservative PUSH surgery in diffuse adenomyosis.
Wu R; Zeng L; Hu Q; Qu X; He F; Bao J; Wei W; Zhang W; Dai W; Li H; Du H; Li C
Hum Fertil (Camb); 2023 Oct; 26(4):720-732. PubMed ID: 37913797
[TBL] [Abstract][Full Text] [Related]
28. Treatment of Adenomyosis with Subcutaneous Etonogestrel Implants: A Clinical Observational Study in 17 Patients.
Wu J; Huang Y; Chen L; Hu J; Zou Y
Med Sci Monit; 2018 Sep; 24():6085-6092. PubMed ID: 30171680
[TBL] [Abstract][Full Text] [Related]
29. Clinical effectiveness and potential long-term benefits of high-intensity focused ultrasound therapy for patients with adenomyosis.
Li W; Mao J; Liu Y; Zhu Y; Li X; Zhang Z; Bai X; Zheng W; Wang L
J Int Med Res; 2020 Dec; 48(12):300060520976492. PubMed ID: 33349096
[TBL] [Abstract][Full Text] [Related]
30. Clinical Efficacy and Safety of Major Uterine Wall Resection and Reconstruction of the Uterus Combined with LNG-IUS for the Treatment of Severe Adenomyosis.
Sun C; Ren XY; Gao Y; Liang ZG; Mou M; Gu HF; Xiao YB
Geburtshilfe Frauenheilkd; 2020 Mar; 80(3):300-306. PubMed ID: 32139919
[No Abstract] [Full Text] [Related]
31. The evaluation of uterine artery embolization as a nonsurgical treatment option for adenomyosis.
Wang S; Meng X; Dong Y
Int J Gynaecol Obstet; 2016 May; 133(2):202-5. PubMed ID: 26868068
[TBL] [Abstract][Full Text] [Related]
32. Uterine adenomyosis and adenomyoma: the surgical approach.
Osada H
Fertil Steril; 2018 Mar; 109(3):406-417. PubMed ID: 29566853
[TBL] [Abstract][Full Text] [Related]
33. Uterine-Sparing Laparoscopic Pelvic Plexus Ablation, Uterine Artery Occlusion, and Partial Adenomyomectomy for Adenomyosis.
Yang W; Liu M; Liu L; Jiang C; Chen L; Qu X; Cheng Z
J Minim Invasive Gynecol; 2017; 24(6):940-945. PubMed ID: 28552655
[TBL] [Abstract][Full Text] [Related]
34. Ultrasound-guided transcervical radiofrequency ablation for symptomatic uterine adenomyosis.
Hai N; Hou Q; Ding X; Dong X; Jin M
Br J Radiol; 2017 Jan; 90(1069):20160119. PubMed ID: 27792415
[TBL] [Abstract][Full Text] [Related]
35. Laparoscopy-guided myometrial biopsy in the definite diagnosis of diffuse adenomyosis.
Jeng CJ; Huang SH; Shen J; Chou CS; Tzeng CR
Hum Reprod; 2007 Jul; 22(7):2016-9. PubMed ID: 17428879
[TBL] [Abstract][Full Text] [Related]
36. [Intermediate and long term clinical effects of uterine arterial embolization with sodium alginate microspheres in treatment of diffuse adenomyosis].
Duan P; Cheng J; Lin M; Cai LL; Hu Z; Jin SX; Hu MP
Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):272-5. PubMed ID: 18843968
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of medical treatment for adenomyosis after adenomyomectomy.
Li Q; Yuan M; Li N; Zhen Q; Chen C; Wang G
J Obstet Gynaecol Res; 2020 Oct; 46(10):2092-2099. PubMed ID: 32725682
[TBL] [Abstract][Full Text] [Related]
38. Laparoscopic adenomyomectomy combined with levonorgestrel-releasing intrauterine system in the treatment of adenomyosis: Feasibility and effectiveness.
Sun F; Zhang Y; You M; Yang Y; Yu Y; Xu H
J Obstet Gynaecol Res; 2021 Feb; 47(2):613-620. PubMed ID: 33174318
[TBL] [Abstract][Full Text] [Related]
39. Conservative surgical management for diffuse uterine adenomyosis.
Nishida M; Takano K; Arai Y; Ozone H; Ichikawa R
Fertil Steril; 2010 Jul; 94(2):715-9. PubMed ID: 19406396
[TBL] [Abstract][Full Text] [Related]
40. T2 relaxometry mapping in demonstrating layered uterine architecture: parameter optimization and utility in endometrial carcinoma and adenomyosis: a feasibility study.
Ghosh A; Singh T; Bagga R; Srinivasan R; Singla V; Khandelwal N
Br J Radiol; 2018 Jan; 91(1081):20170377. PubMed ID: 28936889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
